Deutsche Bank Starts Genesis Healthcare (GEN) at Hold
Get Alerts GEN Hot Sheet
Rating Summary:
8 Buy, 5 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 10
Join SI Premium – FREE
Deutsche Bank initiated coverage on Genesis Healthcare (NYSE: GEN) with a Hold rating and a price target of $8.00.
Analyst Dana Nentin said, "While we see equity upside through the company’s focus on (1) improving skilled mix through its unique bifurcation strategy and development of specialized units, (2) continued momentum in its contract therapy business, and (3) upside opportunities with SKH deal synergies, we find it hard to justify a Buy rating at this point due to its trading liquidity, private equity overhang, and concentration in SNFs (especially in the context of potential SNF payment reform)."
For an analyst ratings summary and ratings history on GenOn Energy click here. For more ratings news on GenOn Energy click here.
Shares of GenOn Energy closed at $7.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monness, Crespi, Hardt Downgrades Palantir Technologies Inc. (PLTR) to Sell on 'egregiously rich valuation... darkest days of this economic downturn are ahead of us'
- Safran SA (SAF:FP) (SAFRY) PT Raised to EUR211 at Citi, 'remain positive on the aftermarket'
- PICC Property & Casualty Co Ltd (2328:HK) (PPCCY) PT Raised to HK$12 at HSBC
Create E-mail Alert Related Categories
Analyst Comments, New CoverageRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!